CellaVision AB (publ) (LON:0MR5)

Market Cap	336.54M
Revenue (ttm)	57.67M
Net Income (ttm)	11.73M
Shares Out	n/a
EPS (ttm)	0.49
PE Ratio	28.69
Forward PE	24.90
Dividend	0.20 (0.11%)
Ex-Dividend Date	May 7, 2025

Volume	131
Average Volume	547
Open	184.40
Previous Close	183.60
Day's Range	183.00 - 183.40
52-Week Range	148.32 - 292.50
Beta	1.23
RSI	47.67
Earnings Date	Jul 18, 2025

About CellaVision AB

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides digital hematology microscopy solutions, covering analyzers and instruments; and hardware products, including in vitro diagnostics IVD for laboratories; smear makers, stainers, stains, and staining protocols; DIFF-Line, a hematology lab that handles a smaller amount daily blood samples, as well as consists of three instruments, such as CellaVision DC-1, RAL SmearBox, and RAL StainBox...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1994
• Employees: 219
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0MR5

Financial Performance

In 2024, CellaVision AB's revenue was 723.22 million, an increase of 6.78% compared to the previous year's 677.29 million. Earnings were 140.72 million, an increase of 7.99%.

Financial numbers in SEK